Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epic... Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases. Show more
Full-Year 2024 Total Revenue Growth of 20% and Adjusted EBITDA Growth of Approximately 55% MACI Full-Year 2024 Revenue Growth of 20%, with Fourth Quarter Revenue of $68.2 to $68.7 Million...
CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.48 | 2.58109522149 | 57.34 | 61.99 | 56.91 | 379480 | 59.47931896 | CS |
4 | 1.555 | 2.71544573474 | 57.265 | 61.99 | 53 | 452919 | 58.65106621 | CS |
12 | 4.32 | 7.92660550459 | 54.5 | 61.99 | 51.53 | 398609 | 57.31918908 | CS |
26 | 12.82 | 27.8695652174 | 46 | 61.99 | 39.12 | 370443 | 51.02847843 | CS |
52 | 16.35 | 38.4977631269 | 42.47 | 61.99 | 39.12 | 387499 | 49.04922838 | CS |
156 | 25.52 | 76.6366366366 | 33.3 | 61.99 | 17.3 | 412979 | 36.62840356 | CS |
260 | 42.13 | 252.426602756 | 16.69 | 68.94 | 6.78 | 484224 | 34.87690552 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales